Dukhanina Elena A, Kabanova Olga D, Lukyanova Tamara I, Shatalov Yury V, Yashin Denis V, Romanova Elena A, Gnuchev Nikolai V, Galkin Alexander V, Georgiev Georgii P, Sashchenko Lidia P
Laboratory of Molecular Immunogenetics of Cancer, Institute of Gene Biology, Russian Academy of Sciences, University of Oslo, 34/5 Vavilova Street, Moscow 119334, Russia.
Proc Natl Acad Sci U S A. 2009 Aug 18;106(33):13963-7. doi: 10.1073/pnas.0900116106. Epub 2009 Aug 3.
We compare the physical and functional interactions between three widespread multifunctional proteins [metastasin (Mts1/S100A4), innate immunity-related Tag7/PGRP-S, and Hsp70] in two experimental models relevant to host-tumor relationships on humoral and cellular levels. (i) Tag7 and Hsp70 in solution or in a lymphocyte make a stable binary complex that is highly cytotoxic for some tumor cells. Here, we show that Mts1 prevents Tag7.Hsp70 assembly in solution, and an excess of Mts1 disrupts the existing Tag7.Hsp70 complex; accordingly, Tag7.Hsp70 cytotoxicity (exemplified with L929 cells) is diminished in the presence of excess Mts1. (ii) Tag7 exposed on a specialized subset of lymphokine-activated killer cells makes specific contact with Hsp70 exposed on some HLA-negative tumor cells, thus enabling FasL/Fas-mediated induction of apoptosis. Here, we show that some CD4(+)CD25(+) cells coexpose Mts1 with Tag7 and FasL, that Mts1 and Tag7 closely contact the same Hsp70 molecule on the target K562 cell (as evidenced by cross-linking), and that killing of such targets is abolished by Mts1-specific antibodies (or selective removal of Mts1-exposing lymphocytes). Thus, this phenotype active against immunoevasive cancerous cells is defined as CD4(+)CD25(+), FasL(+), Tag7(+)Mts1(+) (approximately 0.5% of total lymphocytes in culture). Remarkably, similar effectors with at least the same activity are often found in fresh donor blood samples (approximately 10(4) effectors/mL). Thus, our models suggest that interactions between the three proteins in different situations may have opposite functional outcomes as regards antitumor defense, immune escape, and metastasis.
我们在体液和细胞水平上,于两个与宿主 - 肿瘤关系相关的实验模型中,比较了三种广泛存在的多功能蛋白[转移抑制蛋白(Mts1/S100A4)、与先天免疫相关的Tag7/PGRP - S和热休克蛋白70(Hsp70)]之间的物理和功能相互作用。(i)溶液中或淋巴细胞中的Tag7和Hsp70形成稳定的二元复合物,对某些肿瘤细胞具有高度细胞毒性。在此,我们表明Mts1可阻止溶液中Tag7.Hsp70的组装,且过量的Mts1会破坏现有的Tag7.Hsp70复合物;相应地,在存在过量Mts1的情况下,Tag7.Hsp70的细胞毒性(以L929细胞为例)会减弱。(ii)淋巴因子激活的杀伤细胞特定亚群上暴露的Tag7与某些HLA阴性肿瘤细胞上暴露的Hsp70进行特异性接触,从而实现FasL/Fas介导的凋亡诱导。在此,我们表明一些CD4(+)CD25(+)细胞同时暴露Mts1、Tag7和FasL,Mts1和Tag通过交联证明与靶K562细胞上的同一Hsp70分子紧密接触,并且这种靶细胞的杀伤可被Mts1特异性抗体(或选择性去除暴露Mts1的淋巴细胞)消除。因此,这种针对免疫逃逸癌细胞的表型被定义为CD4(+)CD25(+)、FasL(+)、Tag7(+)Mts1(+)(约占培养中总淋巴细胞的0.5%)。值得注意的是,在新鲜的供体血样中经常发现具有至少相同活性的类似效应细胞(约10(4)个效应细胞/毫升)。因此,我们的模型表明,在不同情况下这三种蛋白质之间的相互作用在抗肿瘤防御、免疫逃逸和转移方面可能具有相反的功能结果。